Anna Carlsson joined UNION in November 2022 as VP of Medical Affairs. Anna brings more than 16 years of experience from various positions in the biopharmaceutical industry e.g., from AbbVie, LEO Pharma, and SBL Vaccines/Crucell.
With a scientific background in Molecular Life Sciences and having worked many years in Medical Affairs, Anna brings extensive launch preparation, stakeholder engagement, medical writing, and leadership experience. During her time at AbbVie, she was involved in launching Humira in hidradenitis suppurativa, Skyrizi in psoriasis and development of functional capabilities across medical functions. Before joining UNION, Anna worked at the Global Medical Affairs team at LEO Pharma where she was involved in launching tralokinumab (EU: Adtralza and US: Adbry).
Anna holds a Master of Science in Medical Biology from Linköping University, followed by graduate studies at Karolinska University and Science Communication at Uppsala University.